PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
February 21, 2013 | ISSUE NUMBER 289 VOL 10

Biopharm
Get Ready for the Biologics Patent Cliff
Now we need to get ready for the next patent cliff: biologics. So how can biologics brands prepare for it? Paul Gardiner and Dr Cliff Hall propose some late life cycle options ...Read more

Healthcare Reform
Part D Politics: Medicare Drug Rebates or Price Controls
While health care was barely mentioned in the recent State of the Union address, President Obama generated some interest in his proposal to cut Medicare spending by reducing “taxpayer subsidies to prescription drug companies.” That’s code for requiring pharma marketers to pay rebates on medicines provided by Medicare Part D plans to low income “dual eligibles”, writes Jill Wechsler...Read More

Drug Safety
Curb Fake Meds through Track-and-Trace but Forget “Counterfeits”
A new report from the Institute of Medicine (IOM) proposes the strengthening of supply chain tracking through tighter state regulation of drug wholesalers, and a narrowing of the term “counterfeit” to refer to products that infringe on trademarks and intellectual property protections
...Read more

Leveraging New Pharma Technologies to Improve the Customer Experience
LIVE WEBCAST: Wednesday, February 27, 2013 at 2:00 PM to 3:00PM EST
Register Free at: www.pharmexec.com/experience

Marketing
Rethinking Product Lifecycle Management
Pharma professionals adopting the "Drug Life Optimization" approach can wrest more value through strategies that build and promote a drug's brand franchise through its entire lifespan, not simply the product lifecycle
...Read more

Leadership
Pharm Exec's Emerging Pharma Leaders 2013
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input! Tell us who you think should receive Pharmaceutical Executive's Emerging Pharma Leadership Award. Fill out a nomination today
...Read more

Global Health
US Cuts Could Jeopardize Global Health Innovations, Says Report
Cuts to US global health and research programs for diseases such as AIDS, tuberculosis and malaria risk derailing the innovations crucial to fighting these diseases, according a new report
...Read more

// Ann Powell Judge moved from Shire Pharmaceuticals to join Bristol-Myers Squibb (BMS) as Senior VP, Human Resources. // Biotech company Cellerant Therapeutics (San Carlos, CA) named Dr William Reed as VP, Clinical Development. // FDA appointed Dr Richard Moscicki, Senior VP, Head of Clinical Development at Sanofi’s Genzyme division, to the newly created position of Deputy Centre Director for Science Operations at its Center for Drug Evaluation and Research (CDER).

March 5–6: 8th Biosimilars Summit
Washington, DC.


April 10­–11: Global Transparency Reporting Congress
Brussels, Belgium.


April 29–30: 12th Annual Patient Adherence and Support Summit
Philadelphia, PA.


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin


Survey
How has pharma’s reputation changed in recent years?

Click To Vote
 
Quick Links

Should Pharma CEOs Use Social Media?

Daiichi Sankyo Faces Gender Discrimination Lawsuit

Read the New Pharm Exec Global Digest